     United States Senator   Gordon Smith                                                                                                                                                                                                    Advance Stem Cell Research Now Senator Smith Calls for Senate Passage of Stem Cell Research Legislation              May 16th  2006   Washington  DC   U S  Senator Gordon H  Smith  R OR  and a bi partisan group of senators have called for Senate passage of the Stem Cell Research Enhancement Act  HR 810   The legislation is critical to advancing embryonic stem cell research and the potential for treating diseases such as Alzheimers  Parkinsons  diabetes and cardiovascular disease   We cannot ask scientists to deliver cures for todays worst diseases when they are working with yesterdays capabilities  Smith said  Stem cell research is a rapidly advancing field of modern medicine  The Stem Cell Research Enhancement Act will give new hope to millions that the promise of stem cell research can and will be realized in the near future  I urge the Senate to clear the way for this cutting edge medical research   As Americas population ages  more people will become afflicted with disease  Together the estimated annual cost of caring for patients with these diseases is  650 billion  Finding a way to delay the onset of Alzheimers by just five years would reduce the number of cases and spending on this disease by more than 50 percent   Smith noted Senate support is growing and it has been nearly one year since the House passed the Stem Cell Research Enhancement Act  the Senate should not let another day go by without acting  Smith joined Senators Dianne Feinstein  Tom Harkin  Orrin Hatch  Edward Kennedy  and Arlen Specter in advocating for the Stem Cell Research Enhancement Act  HR 810                                                                                                    current Press Release                                                                                                                                           